Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Given Average Recommendation of “Buy” by Brokerages
Shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report) have earned an average rating of “Buy” from the six brokerages that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation, four have issued a buy recommendation and one has issued a strong buy recommendation on […]
Shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report) have earned an average rating of “Buy” from the six brokerages that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation, four have issued a buy recommendation and one has issued a strong buy recommendation on […]
